TipRanks
Corvus Pharmaceuticals Inc (DE:C17)
FRANKFURT:C17
Germany Market
C17
Corvus Pharmaceuticals
RESEARCH TOOLSreports

Corvus Pharmaceuticals (C17) Income Statement

0 Followers

Corvus Pharmaceuticals Income Statement

Last quarter (Q2 2026), Corvus Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Corvus Pharmaceuticals's net income was $-17.96M. See Corvus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -105.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 42.87M$ 27.55M$ 23.41M$ 32.56M$ 38.63M
Depreciation and Amortization
$ 105.00K$ 85.00K$ 151.00K$ 367.00K$ 460.00K
EBITDA
$ -15.18M$ -62.21M$ -26.88M$ -40.94M$ -42.77M
Operating Income
$ -42.97M$ -27.55M$ -23.41M$ -32.56M$ -38.63M
Other Income/Expenses
$ 27.69M$ -34.74M$ -3.62M$ -8.74M$ -4.61M
Pretax Income
$ -15.28M$ -62.29M$ -27.03M$ -41.31M$ -43.24M
Net Income
$ -15.28M$ -62.29M$ -27.03M$ -41.31M$ -43.24M
Per Share Metrics
Basic EPS
$ -0.19$ -1.02$ -0.56$ -0.89$ -1.03
Diluted EPS
$ -0.53$ -1.02$ -0.56$ -0.89$ -1.03
Weighted Average Shares Outstanding
 78.96M 60.99M 48.03M 46.55M 41.85M
Weighted Average Shares Outstanding (Diluted)
 79.74M 60.99M 48.03M 46.55M 41.85M
Currency in USD

Corvus Pharmaceuticals Earnings and Revenue History